Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8645658 | 1.00 | ATM (0.59) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL8645656 | 1.00 | ATM (0.59) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL11744194 | 0.94 | HCAR2 (0.58) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL11746537 | 0.94 | HCAR2 (0.58) | ATMHCAR2TSHRHPGDALDH1A1 | |
| Methacrylic Acid SCHEMBL8425163 | 0.93 | TSHR (0.53) | ATMHCAR2TSHRHPGDALDH1A1 | |
| Methacrylic Acid SCHEMBL8425164 | 0.93 | TSHR (0.53) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL15610424 | 0.93 | HCAR2 (0.59) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL29124286 | 0.93 | HCAR2 (0.59) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL27725777 | 0.93 | HCAR2 (0.59) | ATMHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL1087614 | 0.88 | HCAR2 (0.53) | ATMHCAR2TSHRHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589181-B2 | Absorbent article | LIVEDO CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4584243-B1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-11-05 | — | — | EP | disclosed |
| EP-3957287-B1 | ABSORBENT ARTICLE | LIVEDO CORP (JP) | 2025-10-15 | — | — | EP | disclosed |
| EP-3957288-B1 | ABSORBENT ARTICLE | LIVEDO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4584244-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584245-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584243-A1 | CROSSLINKERS | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025095137-A1 | GELLING AGENT FOR ALKALINE BATTERIES | 三洋化成工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| US-20040191660-A1 | Electrophotographic printing method, monoazo iron complex compound, charge controlling agent using the same and toner using the charge controlling agent | HODOGAYA CHEMICAL CO., LTD. (JP) | 2004-09-30 | — | — | US | disclosed |
| CN-1119707-C | Toner for developing electrostatic image | CANON KK (JP) | 2003-08-27 | — | — | CN | disclosed |
| CN-1107885-C | Toner for developing electrostatic image | CANON KK (JP) | 2003-05-07 | — | — | CN | disclosed |
| US-20030078349-A1 | For use in paper diaper, a physiological napkin, a pad, a paper towel | TAGAWA DAISUKE (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1275669-A1 | CROSSLINKED POLYMER, PROCESS FOR PRODUCING THE SAME, ABSORBENT STRUCTURE, AND ABSORBENT ARTICLE | SANYO CHEMICAL INDUSTRIES, Ltd. (JP) | 2003-01-15 | — | — | EP | disclosed |
| CN-1076108-C | Toner for developing electrostatic image | CANON KK (JP) | 2001-12-12 | — | — | CN | disclosed |
| CN-1041024-C | Toner for developing electrostatic image and process for producting thereof | CANON KK (JP) | 1998-12-02 | — | — | CN | disclosed |
| CN-1110794-A | Toner for developing electrostatic image | CANON KK (JP) | 1995-10-25 | — | — | CN | disclosed |
| CN-1109982-A | Toner for developing electrostatic image | CANON KK (JP) | 1995-10-11 | — | — | CN | disclosed |
| CN-1063560-A | Be used to make the toner and the production method thereof of developing electrostatic image | CANON KK (JP) | 1992-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589181-B2 | Absorbent article | CDH1, CUTA, DSG1 | ATM 2611/4885HCAR2 2803/4885TSHR 4602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.